YOLFTbeta
Nanosonics Ltd

Nanosonics Ltd

NAN · AU · Healthcare / Medical Instruments & Supplies

2.83AUD+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close2.83
Open2.83
Day Range2.82 – 2.90
52-Week Range2.64 – 4.76
Volume615.07K
Market Cap861.60M
P/E (TTM)48.00
Forward P/E80.00
EPS0.06
Dividend Yield0.00%
Beta1.19
50-Day Avg3.10
200-Day Avg3.42

About

Nanosonics Limited engages in the manufacture and commercialization of infection control and decontamination products and related technologies in Australia, North America, Europe, the United Kingdom, the Middle East, and Asia Pacific. It offers trophon, an automated ultrasound probe high-level disinfection device built on hydrogen peroxide chemistry with integrated digital traceability solutions, as well as related consumables and accessories. The company also provides infection control and decontamination products and related technologies. In addition, it is involved in the research, development, and commercialization of the CORIS system, an automated technology designed to transform flexible endoscope reprocessing. The company was incorporated in 2000 and is headquartered in Macquarie Park, Australia.

Company Details

  • SectorHealthcare
  • IndustryMedical Instruments & Supplies
  • CEOMr. Michael C. Kavanagh BSc, M.B.A.
  • Employees508
  • HeadquartersBuilding A, Macquarie Park, NSW, Australia, 2113, Australia
  • Websitehttps://www.nanosonics.com.au

Leadership

  • Mr. Michael C. Kavanagh BSc, M.B.A.CEO, President, MD & Executive Director
  • Mr. Jason Burriss B.Com., C.A.Chief Financial Officer
  • Mr. Rod Lopez M.B.A.Chief Operating Officer
  • Mr. Derek Minihane BSEE, J.D.Chief Technology Officer
  • Mr. Sunny Pillai M.B.A.Chief Information Officer
  • Mr. Jonathan Burdach Ph.D.Chief Medical Affairs & Scientific Officer
  • Ms. Catherine StrongHead of Investor Relations & Corporate Communications
  • Mr. Matthew Carbines B.Com., L.L.B.General Counsel & Company Secretary
  • Ms. Kimberly Hill B.Sc.Chief Marketing Officer & Regional President of Asia Pacific
  • Ms. Jodi Sampson M.A.I.C.D., M.B.A.Chief People & Culture Officer

Financials

Income Statement

Currency: AUD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Revenue1.26M1.37M8.42K1.11M309.00K763.00K2.25M12.30M14.90M21.49M22.21M42.80M67.51M60.70M84.32M99.38M101.83M119.73M167.51M171.56M198.93M203.47M
Growth (%)-+8.41%-99.38%+13100.38%-72.21%+146.93%+194.50%+447.44%+21.12%+44.25%+3.36%+92.65%+57.74%-10.09%+38.92%+17.86%+2.47%+17.57%+39.91%+2.42%+15.95%+2.28%
Cost of Revenue777.00K---121.00K284.00K981.00K4.80M6.43M8.11M7.31M10.63M17.35M15.41M21.51M28.29M26.93M33.58M41.86M37.58M43.27M54.85M
Gross Profit--8.42K-188.00K479.00K1.27M7.50M8.47M13.38M14.90M32.17M50.16M45.29M62.82M71.09M74.91M86.15M125.66M133.99M155.66M148.62M
Gross Margin--100.00%-60.84%62.78%56.34%60.99%56.86%62.28%67.08%75.16%74.30%74.62%74.49%71.54%73.56%71.95%75.01%78.10%78.25%73.04%
Operating Expense--8.74M-10.71M10.37M15.25M14.46M17.42M16.20M21.68M32.54M37.02M42.48M49.16M59.43M66.53M85.36M107.66M124.87M146.73M133.63M
Operating Income---8.73M-10.44M-10.52M-9.89M-13.98M-6.96M-8.95M-2.82M-6.78M-370.00K13.13M2.81M13.66M11.66M8.38M792.00K18.00M9.12M8.93M14.99M
Operating Margin---103619.11%-939.12%-3403.56%-1295.81%-622.30%-56.58%-60.08%-13.12%-30.53%-0.86%19.45%4.63%16.20%11.73%8.23%0.66%10.74%5.31%4.49%7.37%
EBITDA---5.54M-6.90M-10.10M-9.12M-12.97M-6.05M-4.17M-1.11M-3.90M2.06M15.17M7.14M19.21M16.70M15.75M7.86M29.50M21.72M31.82M23.70M
EBITDA Margin---65803.17%-620.77%-3267.96%-1195.02%-577.35%-49.15%-28.02%-5.15%-17.54%4.82%22.47%11.76%22.78%16.80%15.46%6.57%17.61%12.66%16.00%11.65%
Net Income---5.70M-7.15M-8.75M-8.17M-11.21M-4.68M-5.77M-2.60M-5.46M122.00K26.16M5.75M13.60M10.14M8.58M3.74M19.88M12.97M20.68M17.84M
Net Income Margin---67705.65%-642.72%-2833.01%-1071.04%-499.07%-38.04%-38.71%-12.12%-24.58%0.29%38.75%9.47%16.13%10.20%8.42%3.13%11.87%7.56%10.39%8.77%
R&D686.00K1.88M3.36M390.00K3.44M2.37M3.63M3.13M3.17M4.14M4.90M7.30M9.49M9.88M11.38M14.64M16.15M21.48M27.33M32.81M34.70M29.09M
R&D as % of Total Revenue54.44%137.41%39886.04%35.07%1111.65%310.48%161.42%25.49%21.26%19.26%22.07%17.05%14.05%16.28%13.49%14.73%15.86%17.94%16.32%19.12%17.44%14.30%
Interest Expense00000000517.00K555.00K598.00K603.00K77.00K58.00K243.00K344.00K338.00K557.00K771.00K1.10M1.46M1.68M
Interest Expense % of Total Revenue0.00%0.00%0.00%0.00%0.00%0.00%0.00%0.00%3.47%2.58%2.69%1.41%0.11%0.10%0.29%0.35%0.33%0.47%0.46%0.64%0.74%0.83%

Balance Sheet

Currency: AUD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Total Assets2.27M6.99M33.40M25.63M17.58M24.95M16.85M36.66M33.65M33.54M60.37M68.17M99.26M109.18M129.52M148.23M164.57M193.24M226.07M237.34M272.48M310.52M
Total Liabilities3.01M2.78M2.08M1.07M1.27M1.37M2.54M10.66M11.95M13.11M15.69M11.51M12.01M14.88M19.44M24.00M29.01M54.55M62.22M55.14M62.57M93.01M
Total Equity-4.21M31.32M24.56M16.31M23.58M14.31M26.00M21.71M20.43M44.68M56.66M87.25M94.30M110.08M124.23M135.57M138.69M163.86M182.20M209.91M217.51M
Cash1.53M6.59M31.91M24.23M13.88M21.14M12.36M29.31M24.06M21.23M45.72M48.84M62.99M69.43M72.18M91.78M96.03M94.51M112.16M129.55M161.29M155.22M
Total Debt-------7.06M7.57M8.12M8.71M1.74M1.35M946.00K521.00K2.61M2.49M11.71M10.72M9.30M7.69M23.13M
Net Debt---31.91M-24.23M-13.88M-21.14M-12.36M-22.25M-16.49M-13.11M-37.01M-47.10M-61.64M-68.49M-71.66M-89.17M-93.54M-82.80M-101.44M-120.25M-153.61M-132.09M

Cash Flow

Currency: AUD2005-06-302006-06-302007-06-302008-06-302009-06-302010-06-302011-06-302012-06-302013-06-302014-06-302015-06-302016-06-302017-06-302018-06-302019-06-302020-06-302021-06-302022-06-302023-06-302024-06-302025-06-302026-06-30
Operating Cash Flow---4.59M-7.13M-9.14M-7.76M-9.00M-5.03M-4.51M-2.59M-2.42M3.22M16.39M9.01M4.83M22.76M7.32M6.70M23.31M22.78M43.98M22.55M
Investing Cash Flow---711.65K-368.00K-1.40M-182.00K-1.18M-844.00K-1.36M-479.00K-2.31M-1.28M-1.25M-2.81M-2.20M-1.94M-1.38M-6.90M-3.54M-2.36M-8.71M-5.14M
Financing Cash Flow-6.71M30.61M-180.00K185.00K15.20M1.41M22.83M530.00K336.00K28.64M1.69M-457.00K-561.00K-461.00K-1.30M-1.03M-1.97M-2.71M-3.01M-3.30M-23.53M
Capital Expenditure36.00K120.00K711.65K368.00K1.40M182.00K1.18M844.00K1.36M433.00K2.13M1.09M1.06M2.31M1.68M1.94M1.38M6.97M3.57M2.52M8.72M5.14M
Free Cash Flow---5.30M-7.50M-10.53M-7.94M-10.18M-5.87M-5.87M-3.03M-4.56M2.14M15.32M6.70M3.14M20.83M5.93M-271.00K19.74M20.27M35.26M17.41M
Dividends Paid----------28.64M310.00K0---------
FCF to OCF--115.52%105.16%115.28%102.34%113.09%116.78%130.16%116.69%188.19%66.28%93.50%74.31%65.11%91.50%81.12%-4.05%84.68%88.95%80.17%77.22%
Dividend Paid to FCF-----------628.64%14.51%0.00%---------

Earnings

Report DateAug 14, 2014Feb 22, 2016Aug 22, 2016Feb 19, 2017Aug 23, 2017Feb 22, 2018Apr 18, 2018Aug 19, 2018Nov 2, 2018Feb 24, 2019Apr 17, 2019Aug 26, 2019Nov 1, 2019Feb 25, 2020Apr 22, 2020Aug 24, 2020Oct 30, 2020Feb 23, 2021Apr 21, 2021Aug 23, 2021Oct 29, 2021Feb 21, 2022Apr 20, 2022Aug 23, 2022Oct 28, 2022Feb 23, 2023Apr 19, 2023Aug 22, 2023Oct 27, 2023Feb 25, 2024Apr 17, 2024Aug 26, 2024Nov 18, 2024Feb 19, 2025Aug 26, 2025Feb 25, 2027
EPS Estimate0.000.000.000.000.000.000.00-0.000.000.000.000.010.000.010.000.020.000.010.000.020.000.000.00-0.000.000.010.000.010.000.030.000.020.000.010.02-
EPS Actual0.00-0.010.010.070.010.010.000.010.000.020.000.020.000.020.000.010.000.010.000.020.000.010.000.000.000.030.000.000.000.000.000.000.000.030.04-
Surprise-------433.33%-19900.00%-66.67%-53.85%--41.18%--23.08%-0.00%-4900.00%-100.00%-172.73%--100.00%--100.00%--100.00%-180.37%87.79%-
Timing---------------------After-hours-After-hours-After-hours-After-hours------Pre-market-

Key Statistics & Ratios

Market Cap861.60M
Enterprise Value762.42M
Trailing P/E48.00
Forward P/E80.00
PEG Ratio46.36
Price / Sales4.23
Price / Book4.11
EPS0.06
Book Value0.728
Revenue (TTM)203.89M
Gross Profit (TTM)156.81M
EBITDA22.11M
Profit Margin8.75%
Operating Margin7.67%
Return on Equity8.35%
Return on Assets3.68%
Shares Outstanding299.17M
Shares Float274.49M
Beta1.19
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Ownership Breakdown

Institutions
61.37%
Insiders
8.46%
Retail / Other
30.17%

Top Institutional Holders

  • Gofen & Glossberg LLC
    90.05K0.03%

Top Fund Holders

  • Fidelity Select Portfolios - Medical Technology & Devices Port
    21.80M7.24%
  • Vanguard International Stock Index-Total Intl Stock Indx
    3.74M1.24%
  • Fidelity Advisor Stock Selector Mid Cap Fund
    2.18M0.72%
  • Fidelity International Small Cap Fund
    1.89M0.63%
  • Vanguard Tax Managed Fund-Vanguard Developed Markets Index Fund
    1.50M0.50%
  • iShares Core MSCI EAFE ETF
    1.23M0.41%
  • iShares MSCI EAFE Small Cap ETF
    1.14M0.38%
  • Investment Managers Ser Tr-WCM International Small Cap Growth Fd
    902.61K0.30%
  • Wasatch International Opportunities Fund
    887.91K0.29%
  • Brinker Capital Destinations Tr-Destinations International Equity Fd
    690.91K0.23%